000 | 01830 a2200589 4500 | ||
---|---|---|---|
005 | 20250517032040.0 | ||
264 | 0 | _c20160603 | |
008 | 201606s 0 0 eng d | ||
022 | _a1878-0261 | ||
024 | 7 |
_a10.1016/j.molonc.2015.04.002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWoan, K V | |
245 | 0 | 0 |
_aTargeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation. _h[electronic resource] |
260 |
_bMolecular oncology _cAug 2015 |
||
300 |
_a1447-1457 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aG1 Phase _xdrug effects |
650 | 0 | 4 | _aHistone Deacetylase 6 |
650 | 0 | 4 |
_aHistone Deacetylase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aHistone Deacetylases _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMelanoma, Experimental _xenzymology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
700 | 1 | _aLienlaf, M | |
700 | 1 | _aPerez-Villaroel, P | |
700 | 1 | _aLee, C | |
700 | 1 | _aCheng, F | |
700 | 1 | _aKnox, T | |
700 | 1 | _aWoods, D M | |
700 | 1 | _aBarrios, K | |
700 | 1 | _aPowers, J | |
700 | 1 | _aSahakian, E | |
700 | 1 | _aWang, H W | |
700 | 1 | _aCanales, J | |
700 | 1 | _aMarante, D | |
700 | 1 | _aSmalley, K S M | |
700 | 1 | _aBergman, J | |
700 | 1 | _aSeto, E | |
700 | 1 | _aKozikowski, A | |
700 | 1 | _aPinilla-Ibarz, J | |
700 | 1 | _aSarnaik, A | |
700 | 1 | _aCelis, E | |
700 | 1 | _aWeber, J | |
700 | 1 | _aSotomayor, E M | |
700 | 1 | _aVillagra, A | |
773 | 0 |
_tMolecular oncology _gvol. 9 _gno. 7 _gp. 1447-1457 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.molonc.2015.04.002 _zAvailable from publisher's website |
999 |
_c24884743 _d24884743 |